• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

MassDevice Earnings Roundup

Medtronic to separate Diabetes business unit

May 21, 2025 By Sean Whooley

Medtronic Simplera Sync CGM with MiniMed 780G (1)

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company. The medtech giant said the strategic decision can create “a more focused Medtronic” with a more simplified portfolio in high-margin growth markets. At the same time, it creates an independent, scaled leader in diabetes. The new company — […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Initial Public Offering (IPO), MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Medtronic

Embecta to undergo further restructuring, lowers guidance amid tariff impact

May 9, 2025 By Sean Whooley

BD Diabetes Spinoff Embecta

Embecta (Nasdaq:EMBC) stock was down today after news of restructuring and mixed second-quarter results. Shares of EMBC were down more than 8% to $12.12 apiece near the close of trading today. While the company continues to work through the discontinuation of its insulin patch pump program — the plan for which it says is substantially […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology Tagged With: embecta

Senseonics posts Q2 sales beat, submits 365-day CGM for CE mark

May 8, 2025 By Sean Whooley

Senseonics logo

Senseonics (NYSE:SENS) shares dipped after hours today on first-quarter results that beat revenue projections on Wall Street. Shares of SENS fell 5% to 70¢ apiece in post-market trading today. The Germantown, Maryland-based long-term implantable continuous glucose monitor maker reported losses of $14.3 million. That equals 2¢ per share on sales of $6.26 million for the […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Implants, MassDevice Earnings Roundup, Patient Monitoring, Technology Tagged With: Senseonics

Beta Bionics posts Q1 sales beat, raises 2025 guidance

May 6, 2025 By Sean Whooley

Beta Bionics Logo (1)

Beta Bionics (Nasdaq:BBNX) shares remained unmoved after hours today on first-quarter results that topped the consensus sales forecast. Following its first-quarter performance, Beta Bionics increased its full-year guidance. After previously projecting between $80 million and $85 million in revenue, it now expects between $82 million and $87 million. The Irvine, California-based automated insulin delivery technology developer […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Beta Bionics

Analysts are high on Dexcom after Q1 results, $750M repurchase program

May 1, 2025 By Sean Whooley

Dexcom updated Logo

Dexcom (Nadsaq:DXCM) shares rose after hours today on first-quarter results that came in mixed compared to the consensus forecast. Shares of DXCM ticked up 3% to $72.30 apiece in post-market trading on Thursday. However, before hours on Friday, shares fell 1.6% to $70.26 apiece. The San Diego-based continuous glucose monitor (CGM) maker reported profits of […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Dexcom

Tandem stock rises after hours on Q1 sales beat

April 30, 2025 By Sean Whooley

Tandem Diabetes Care updated logo

Tandem Diabetes Care (Nasdaq:TNDM) shares got a boost after the market closed today on first-quarter results that beat the consensus forecast. Shares of TNDM ticked up 6.2% to $17.89 apiece in post-market trading today. The San Diego-based automated insulin delivery technology company reported losses of $130.56 million. That equals 1.97 per share on sales of […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Tandem Diabetes Care

Beta Bionics posts Q4 sales beat to cap off ‘momentum-building year’

March 25, 2025 By Sean Whooley

Beta Bionics iLet bionic pancreas with Dexcom G7 and Abbott FreeStyle Libre 3 Plus

Beta Bionics (Nasdaq:BBNX) shares rose after hours today on fourth-quarter results that topped the consensus sales forecast. Shares of BBNX ticked up nearly 2% to $15.50 apiece in poost-market trading today. This is the company’s first quarterly earnings report after it went public through a $234.6 million IPO in January. The Irvine, California-based automated insulin […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Beta Bionics

Senseonics expects to double global patient base in 2025, progresses with pump integration

March 3, 2025 By Sean Whooley

Senseonics logo

Senseonics (NYSE:SENS) shares ticked up after hours today on fourth-quarter results that came in ahead of the consensus forecast. Shares of SENS went up nearly 7% to 93¢ apiece in post-market trading today. The Germantown, Maryland-based long-term implantable continuous glucose monitor maker reported losses of $15.5 million for the quarter. That equals losses 2¢ per […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Implants, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Ascensia Diabetes Care, Senseonics

Pump shipments increase by 25% in Q4 sales beat for Tandem

February 26, 2025 By Sean Whooley

Tandem Diabetes Care updated logo

Tandem Diabetes Care (Nasdaq:TNDM) shares took a hit after hours today on fourth-quarter results that topped the consensus sales forecast. Shares of TNDM fell 11% to $29.88 apiece in post-market trading today. The San Diego-based automated insulin delivery technology company reported profits of $755,000. That equals 1¢ per share on sales of $282.65 million for […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Tandem Diabetes Care

Insulet sales increase 22% in 2024, Q4 performance beats Street

February 20, 2025 By Sean Whooley

Insulet logo

Insulet (Nasdaq:PODD) shares dipped after hours today on fourth-quarter results that came in ahead of the consensus forecast. Shares of PODD fell 2.7% to $280.66 apiece in post-market trading on Thursday, Feb. 21. By midday trading on Friday, Feb. 22, shares were down 2.4%, at 281.36. The Acton, Massachusetts–based automated insulin delivery technology maker reported […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Insulet

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 38
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS